Drotaverine interacts with the L-type Ca(2+) channel in pregnant rat uterine membranes

Eur J Pharmacol. 2002 Aug 2;449(1-2):55-60. doi: 10.1016/s0014-2999(02)01993-3.

Abstract

The effect of the isoquinoline derivative, drotaverine on the specific binding of [(3)H]nitrendipine and [(3)H]diltiazem to pregnant rat uterine membranes was examined. Drotaverine inhibited the specific [(3)H]nitrendipine and [(3)H]diltiazem bindings with IC(50) values of 5.6 and 2.6 microM, respectively. Saturation studies showed that diltiazem caused a significant increase in the maximum binding density without changing the K(D) of [(3)H]nitrendipine while drotaverine increased both the K(D) and the B(max) of [3H]nitrendipine. The dissociation kinetics of both [3H]nitrendipine and [(3)H]diltiazem were accelerated by drotaverine. These results suggest that drotaverine has a negative allosteric interaction with the binding sites for 1,4-dihydropyridines and 1,5-benzothiazepines on the L-type Ca(2+) channel in pregnant rat uterine membranes, which may have implications as to the potential usefulness of this drug in aiding child delivery.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors
  • Animals
  • Binding, Competitive / drug effects
  • Calcium Channel Blockers / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / drug effects*
  • Calcium Channels, L-Type / metabolism
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Diltiazem / metabolism
  • Diltiazem / pharmacology
  • Female
  • Half-Life
  • In Vitro Techniques
  • Kinetics
  • Membranes / drug effects
  • Membranes / metabolism
  • Nitrendipine / metabolism
  • Nitrendipine / pharmacology
  • Papaverine / analogs & derivatives*
  • Papaverine / metabolism
  • Papaverine / pharmacology*
  • Parasympatholytics / pharmacology
  • Phosphodiesterase Inhibitors / pharmacology
  • Pregnancy
  • Pregnancy, Animal / physiology*
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Uterus / drug effects
  • Uterus / metabolism*

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Parasympatholytics
  • Phosphodiesterase Inhibitors
  • drotaverin
  • Nitrendipine
  • Papaverine
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Diltiazem